Published in Annu Rev Biomed Eng on January 01, 2000
Hydrogels in regenerative medicine. Adv Mater (2009) 3.80
Wearable and implantable wireless sensor network solutions for healthcare monitoring. Sensors (Basel) (2011) 3.35
High-water-content mouldable hydrogels by mixing clay and a dendritic molecular binder. Nature (2010) 3.18
Controlling hydrogelation kinetics by peptide design for three-dimensional encapsulation and injectable delivery of cells. Proc Natl Acad Sci U S A (2007) 2.87
Polymers for drug delivery systems. Annu Rev Chem Biomol Eng (2010) 1.66
Design properties of hydrogel tissue-engineering scaffolds. Expert Rev Med Devices (2011) 1.47
Maleimide cross-linked bioactive PEG hydrogel exhibits improved reaction kinetics and cross-linking for cell encapsulation and in situ delivery. Adv Mater (2011) 1.43
Artificial Molecular Machines. Chem Rev (2015) 1.31
From 3D to 2D: a review of the molecular imprinting of proteins. Biotechnol Prog (2006) 1.25
Yielding Behavior in Injectable Hydrogels from Telechelic Proteins. Macromolecules (2010) 1.21
Nanocomposite hydrogels for biomedical applications. Biotechnol Bioeng (2013) 1.15
Tissue formation and vascularization in anatomically shaped human joint condyle ectopically in vivo. Tissue Eng Part A (2009) 1.15
Novel complexation hydrogels for oral peptide delivery: in vitro evaluation of their cytocompatibility and insulin-transport enhancing effects using Caco-2 cell monolayers. J Biomed Mater Res A (2003) 1.15
Highly tunable elastomeric silk biomaterials. Adv Funct Mater (2014) 1.14
Effects of molecular weight and loading on matrix metalloproteinase-2 mediated release from poly(ethylene glycol) diacrylate hydrogels. AAPS J (2012) 1.12
Degradable, thermo-sensitive poly(N-isopropyl acrylamide)-based scaffolds with controlled porosity for tissue engineering applications. Biomacromolecules (2010) 1.10
Rational design of network properties in guest-host assembled and shear-thinning hyaluronic acid hydrogels. Biomacromolecules (2013) 1.09
Engineering biomaterial systems to enhance viral vector gene delivery. Mol Ther (2011) 1.07
Mesenchymal stem cells for craniofacial tissue regeneration: designing hydrogel delivery vehicles. J Dent Res (2009) 1.04
Tunable mechanical stability and deformation response of a resilin-based elastomer. Biomacromolecules (2011) 1.02
Mussel-inspired silver-releasing antibacterial hydrogels. Biomaterials (2012) 1.01
Multifunctional, biocompatible supramolecular hydrogelators consist only of nucleobase, amino acid, and glycoside. J Am Chem Soc (2011) 0.99
Microfabricated implants for applications in therapeutic delivery, tissue engineering, and biosensing. Lab Chip (2008) 0.99
Engineering design and molecular dynamics of mucoadhesive drug delivery systems as targeting agents. Eur J Pharm Biopharm (2008) 0.97
Development of hydrogel-based keratoprostheses: a materials perspective. Biotechnol Prog (2008) 0.95
Reinforcement of Shear Thinning Protein Hydrogels by Responsive Block Copolymer Self-Assembly. Adv Funct Mater (2013) 0.95
Hydrogels in Healthcare: From Static to Dynamic Material Microenvironments. Acta Mater (2013) 0.94
Hydrogels for osteochondral repair based on photocrosslinkable carbamate dendrimers. Biomacromolecules (2008) 0.92
The hydrogel nature of mammalian cytoplasm contributes to osmosensing and extracellular pH sensing. Biophys J (2009) 0.92
Synthesis and characterization of pectin/PVP hydrogel membranes for drug delivery system. AAPS PharmSciTech (2008) 0.91
Semiconductor nanoparticle-based hydrogels prepared via self-initiated polymerization under sunlight, even visible light. Sci Rep (2013) 0.90
Dependence of Self-Assembled Peptide Hydrogel Network Structure on Local Fibril Nanostructure. Macromolecules (2009) 0.89
Designing bioactive delivery systems for tissue regeneration. Ann Biomed Eng (2010) 0.88
Preparation and characterization of electrospun PLCL/Poloxamer nanofibers and dextran/gelatin hydrogels for skin tissue engineering. PLoS One (2014) 0.86
Preparation and characterization of hybrid pH-sensitive hydrogels of chitosan-co-acrylic acid for controlled release of verapamil. J Mater Sci Mater Med (2010) 0.86
Evaluation of cell-laden polyelectrolyte hydrogels incorporating poly(l-Lysine) for applications in cartilage tissue engineering. Biomaterials (2016) 0.86
Facile formation of dynamic hydrogel microspheres for triggered growth factor delivery. Acta Biomater (2010) 0.86
A novel approach for reducing ischemic mitral regurgitation by injection of a polymer to reverse remodel and reposition displaced papillary muscles. Circulation (2008) 0.85
Material properties of biofilms-a review of methods for understanding permeability and mechanics. Rep Prog Phys (2015) 0.84
Structural and molecular micropatterning of dual hydrogel constructs for neural growth models using photochemical strategies. Biomed Microdevices (2013) 0.84
Therapeutic strategies based on polymeric microparticles. J Biomed Biotechnol (2012) 0.83
Solid-phase synthesis and kinetic characterization of fluorogenic enzyme-degradable hydrogel cross-linkers. Biomacromolecules (2006) 0.83
Hydrogels and scaffolds for immunomodulation. Adv Mater (2014) 0.82
Microfabrication technologies for oral drug delivery. Adv Drug Deliv Rev (2011) 0.82
pH-responsive hydrogels with dispersed hydrophobic nanoparticles for the oral delivery of chemotherapeutics. J Biomed Mater Res A (2012) 0.81
Critical factors affecting cell encapsulation in superporous hydrogels. Biomed Mater (2012) 0.81
An interplay between electrostatic and polar interactions in peptide hydrogels. Biopolymers (2013) 0.80
Robust self-healing hydrogels assisted by cross-linked nanofiber networks. Sci Rep (2013) 0.80
Covalently immobilized biomolecule gradient on hydrogel surface using a gradient generating microfluidic device for a quantitative mesenchymal stem cell study. Biomicrofluidics (2012) 0.79
Study of the near-neutral pH-sensitivity of chitosan/gelatin hydrogels by turbidimetry and microcantilever deflection. Biotechnol Bioeng (2006) 0.79
PEG-maleimide hydrogels for protein and cell delivery in regenerative medicine. Ann Biomed Eng (2013) 0.79
Spatial control of cell gene expression by siRNA gradients in biodegradable hydrogels. Adv Healthc Mater (2014) 0.79
PEG-penetrated chitosan-alginate co-polysaccharide-based partially and fully cross-linked hydrogels as ECM mimic for tissue engineering applications. Prog Biomater (2015) 0.78
Preparation and characterization of novel biocompatible cryogels of poly (vinyl alcohol) and egg-albumin and their water sorption study. J Mater Sci Mater Med (2006) 0.78
Biopolymer-connected liposome networks as injectable biomaterials capable of sustained local drug delivery. Biomacromolecules (2012) 0.78
B(12)-mediated, long wavelength photopolymerization of hydrogels. J Am Chem Soc (2015) 0.78
Recent advances in thromboresistant and antimicrobial polymers for biomedical applications: just say yes to nitric oxide (NO). Biomater Sci (2016) 0.78
Multi-responsive hydrogels for drug delivery and tissue engineering applications. Regen Biomater (2014) 0.78
Design and synthesis of nonionic copolypeptide hydrogels with reversible thermoresponsive and tunable physical properties. Biomacromolecules (2015) 0.78
Evaluation of BSA protein release from hollow hydroxyapatite microspheres into PEG hydrogel. Mater Sci Eng C Mater Biol Appl (2013) 0.78
Effect of Crosslinking Agent Concentration on the Properties of Unmedicated Hydrogels. Pharmaceutics (2015) 0.77
Poly(ethylene glycol) hydrogels with adaptable mechanical and degradation properties for use in biomedical applications. Macromol Biosci (2014) 0.77
Characterization of glycidyl methacrylate - crosslinked hyaluronan hydrogel scaffolds incorporating elastogenic hyaluronan oligomers. Acta Biomater (2010) 0.77
Synthesis, physiochemical characterization, and biocompatibility of a chitosan/dextran-based hydrogel for postsurgical adhesion prevention. J Mater Sci Mater Med (2014) 0.77
Transport of biological molecules in surfactant-alginate composite hydrogels. Acta Biomater (2011) 0.77
Membranes to achieve immunoprotection of transplanted islets. Front Biosci (Landmark Ed) (2014) 0.77
Salt and osmosensing: role of cytoplasmic hydrogel. Pflugers Arch (2015) 0.76
Macromolecular Diffusion in Self-Assembling Biodegradable Thermosensitive Hydrogels. Macromolecules (2010) 0.76
Drying and storage effects on poly(ethylene glycol) hydrogel mechanical properties and bioactivity. J Biomed Mater Res A (2013) 0.76
Biomedical microelectromechanical systems (BioMEMS): Revolution in drug delivery and analytical techniques. Saudi Pharm J (2013) 0.76
Synthetic hydrogels mimicking basement membrane matrices to promote cell-matrix interactions. Matrix Biol (2016) 0.76
Reducing the Oxidation Level of Dextran Aldehyde in a Chitosan/Dextran-Based Surgical Hydrogel Increases Biocompatibility and Decreases Antimicrobial Efficacy. Int J Mol Sci (2015) 0.75
An Injectable and Drug-loaded Supramolecular Hydrogel for Local Catheter Injection into the Pig Heart. J Vis Exp (2015) 0.75
Evaluation of stability and biocompatibility of PHEMA-PMMA keratoprosthesis by penetrating keratoplasty in rabbits. Lab Anim Res (2016) 0.75
Enhanced wettability of SU-8 photoresist through a photografting procedure for bioanalytical device applications. J Micromech Microeng (2008) 0.75
Chemically cross-linked poly(acrylic-co-vinylsulfonic) acid hydrogel for the delivery of isosorbide mononitrate. ScientificWorldJournal (2013) 0.75
Progress and challenges of the bioartificial pancreas. Nano Converg (2016) 0.75
Comparative Study of Ultrasonication-Induced and Naturally Self-Assembled Silk Fibroin-Wool Keratin Hydrogel Biomaterials. Int J Mol Sci (2016) 0.75
Development of a strategy to functionalize a dextrin-based hydrogel for animal cell cultures using a starch-binding module fused to RGD sequence. BMC Biotechnol (2008) 0.75
Enhanced mucoadhesive capacity of novel co-polymers for oral protein delivery. J Biomater Sci Polym Ed (2011) 0.75
Nanoengineered Platforms to Guide Pluripotent Stem Cell Fate. J Nanomed Nanotechnol (2014) 0.75
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res (1997) 665.31
The sequence of the human genome. Science (2001) 101.55
Comparative genomics of the eukaryotes. Science (2000) 26.62
HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature (1996) 20.59
Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med (2001) 12.38
The vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP) channel opener. EMBO J (2001) 7.97
The pyroptosome: a supramolecular assembly of ASC dimers mediating inflammatory cell death via caspase-1 activation. Cell Death Differ (2007) 7.74
Robust perfect adaptation in bacterial chemotaxis through integral feedback control. Proc Natl Acad Sci U S A (2000) 7.67
Engineering the provitamin A (beta-carotene) biosynthetic pathway into (carotenoid-free) rice endosperm. Science (2000) 7.53
Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med (1999) 7.04
Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia (2006) 6.31
A potential vulnerability locus for schizophrenia on chromosome 6p24-22: evidence for genetic heterogeneity. Nat Genet (1995) 5.87
Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression. Nat Genet (2001) 5.80
Hyperpolarizing vasodilators activate ATP-sensitive K+ channels in arterial smooth muscle. Science (1989) 5.60
The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation. Nat Genet (1997) 5.55
Sites of specific B cell activation in primary and secondary responses to T cell-dependent and T cell-independent antigens. Eur J Immunol (1991) 5.38
The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J Biol Chem (1995) 5.36
Indium phosphide nanowires as building blocks for nanoscale electronic and optoelectronic devices. Nature (2001) 5.09
A kinase-cyclin pair in the RNA polymerase II holoenzyme. Nature (1995) 4.93
Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility. Neurology (2001) 4.84
A genetic map and recombination parameters of the human malaria parasite Plasmodium falciparum. Science (1999) 4.75
In vivo evidence of structural brain asymmetry in musicians. Science (1995) 4.71
HCFA's racial and ethnic data: current accuracy and recent improvements. Health Care Financ Rev (2000) 4.67
Electrostatic interactions of S4 voltage sensor in Shaker K+ channel. Neuron (1995) 4.49
Generation of a prostate epithelial cell-specific Cre transgenic mouse model for tissue-specific gene ablation. Mech Dev (2001) 4.47
Identification of a chlamydial protease-like activity factor responsible for the degradation of host transcription factors. J Exp Med (2001) 4.27
CSF tau/Abeta42 ratio for increased risk of mild cognitive impairment: a follow-up study. Neurology (2007) 4.24
Sequence specificity in the dimerization of transmembrane alpha-helices. Biochemistry (1992) 4.19
An essential role in liver development for transcription factor XBP-1. Genes Dev (2000) 4.17
Comparative analysis of 1196 orthologous mouse and human full-length mRNA and protein sequences. Genome Res (1996) 4.11
The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism. Nature (2000) 4.00
Separation of human breast cancer cells from blood by differential dielectric affinity. Proc Natl Acad Sci U S A (1995) 4.00
Nucleotide sequence of the G protein gene of human respiratory syncytial virus reveals an unusual type of viral membrane protein. Proc Natl Acad Sci U S A (1985) 3.93
Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation. Nat Neurosci (2001) 3.85
Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo. Gene Ther (2003) 3.85
Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation. J Biol Chem (1998) 3.77
Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J Biol Chem (1994) 3.73
The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: outcome of a pilot clinical study. Leukemia (2008) 3.69
Role of miR-143 targeting KRAS in colorectal tumorigenesis. Oncogene (2009) 3.64
Progression of kidney dysfunction in the community-dwelling elderly. Kidney Int (2006) 3.64
A local alignment tool for very long DNA sequences. Comput Appl Biosci (1995) 3.58
Pten regulates neuronal soma size: a mouse model of Lhermitte-Duclos disease. Nat Genet (2001) 3.48
The beta2-adrenergic receptor/betaarrestin complex recruits the clathrin adaptor AP-2 during endocytosis. Proc Natl Acad Sci U S A (1999) 3.43
The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease. Cell Death Differ (2009) 3.43
Rapid clearance of fetal DNA from maternal plasma. Am J Hum Genet (1999) 3.39
Nuclear receptor corepressors partner with class II histone deacetylases in a Sin3-independent repression pathway. Genes Dev (2000) 3.38
Mutation in the silencing gene SIR4 can delay aging in S. cerevisiae. Cell (1995) 3.37
Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med (1995) 3.32
Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D(2) receptor parameter measurements in ventral striatum. J Cereb Blood Flow Metab (2001) 3.31
Proton-pump inhibitors and risk of fractures: an update meta-analysis. Osteoporos Int (2016) 3.30
CCR6 mediates dendritic cell localization, lymphocyte homeostasis, and immune responses in mucosal tissue. Immunity (2000) 3.28
Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. J Clin Oncol (2000) 3.24
Influenza virus hemagglutinin and neuraminidase cytoplasmic tails control particle shape. EMBO J (1997) 3.23
BCL-6 protein is expressed in germinal-center B cells. Blood (1995) 3.18
Efficacies of different preparations of glucosamine for the treatment of osteoarthritis: a meta-analysis of randomised, double-blind, placebo-controlled trials. Int J Clin Pract (2013) 3.16
The EGF-CFC protein one-eyed pinhead is essential for nodal signaling. Cell (1999) 3.15
A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation. Nat Med (1998) 3.15
Aberrant recruitment of the nuclear receptor corepressor-histone deacetylase complex by the acute myeloid leukemia fusion partner ETO. Mol Cell Biol (1998) 3.13
A beta-arrestin/green fluorescent protein biosensor for detecting G protein-coupled receptor activation. J Biol Chem (1997) 3.12
Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction. N Engl J Med (1998) 3.05
Activation of the Wnt signaling pathway: a molecular mechanism for lithium action. Dev Biol (1997) 3.03
Applications of network BLAST server. Methods Enzymol (1996) 3.03
Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma. Cancer Res (1999) 2.87
Automated analysis of protein NMR assignments using methods from artificial intelligence. J Mol Biol (1997) 2.86
Lethal mutagenesis of HIV with mutagenic nucleoside analogs. Proc Natl Acad Sci U S A (1999) 2.85
A cardiac myocyte vascular endothelial growth factor paracrine pathway is required to maintain cardiac function. Proc Natl Acad Sci U S A (2001) 2.77
Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia. Clin Cancer Res (2000) 2.71
High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport. Atherosclerosis (1996) 2.70
A meta-analysis of the efficacy of over-the-counter nicotine replacement. Tob Control (2003) 2.67
Mediation of tubuloglomerular feedback by adenosine: evidence from mice lacking adenosine 1 receptors. Proc Natl Acad Sci U S A (2001) 2.65
Efficiency of signalling through cytokine receptors depends critically on receptor orientation. Nature (1998) 2.65
Changes in Friend murine erythroleukaemia cell membranes during induced differentiation determined by electrorotation. Biochim Biophys Acta (1994) 2.65
Association of an activator with an RNA polymerase II holoenzyme. Genes Dev (1995) 2.61
Mitochondrial genotype associated with longevity. Lancet (1998) 2.58
Pathway leading to correctly folded beta-tubulin. Cell (1996) 2.55
Hormonal changes in the grains of rice subjected to water stress during grain filling. Plant Physiol (2001) 2.52
PET imaging of serotonin 1A receptor binding in depression. Biol Psychiatry (1999) 2.48
Apolipoprotein E: from atherosclerosis to Alzheimer's disease and beyond. Curr Opin Lipidol (1999) 2.48
HIV-1 subtype and second-receptor use. Nature (1996) 2.46
Regulation of HeLa cell transferrin receptors. J Biol Chem (1982) 2.46
Case study of the effects of atmospheric aerosols and regional haze on agriculture: an opportunity to enhance crop yields in China through emission controls? Proc Natl Acad Sci U S A (1999) 2.44
Proteolytic activation of protein kinase C delta by an ICE/CED 3-like protease induces characteristics of apoptosis. J Exp Med (1996) 2.42
Pluripotency factors Lin28 and Oct4 identify a sub-population of stem cell-like cells in ovarian cancer. Oncogene (2010) 2.42
Cellular mechanisms for developmental toxicity of chlorpyrifos: targeting the adenylyl cyclase signaling cascade. Toxicol Appl Pharmacol (1997) 2.42
Stoichiometric and steric principles governing repression by nuclear hormone receptors. Genes Dev (1997) 2.41
Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations. J Natl Cancer Inst (1999) 2.41
Arterial dilations in response to calcitonin gene-related peptide involve activation of K+ channels. Nature (1990) 2.39
The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjögren's syndrome. Ann Rheum Dis (2003) 2.34
HIV knowledge and risk behaviour of female sex workers in Yunnan Province, China: potential as bridging groups to the general population. AIDS Care (2005) 2.34
Enhanced production and oligomerization of the 42-residue amyloid beta-protein by Chinese hamster ovary cells stably expressing mutant presenilins. J Biol Chem (1997) 2.33
Alpha(v)beta3 and alpha(v)beta5 integrin expression in glioma periphery. Neurosurgery (2001) 2.30
A comparison of batch effect removal methods for enhancement of prediction performance using MAQC-II microarray gene expression data. Pharmacogenomics J (2010) 2.30
An assessment of the potential for reducing future combat deaths through medical technologies and training. J Trauma (2002) 2.29
Diverse hepatitis C virus glycoproteins mediate viral infection in a CD81-dependent manner. J Virol (2004) 2.26
Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. Clin Chem (1999) 2.26
Poly (ADP-ribose) polymerase, nitric oxide and cell death. Trends Pharmacol Sci (1999) 2.25
Diffusion tensor imaging of the developing mouse brain. Magn Reson Med (2001) 2.20